SCHEMBL1031156

SCHEMBL1031156

O=S(=O)(NC1CC1)c1cccc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 3/20 0.53
KDM4E B2RXH2 2/20 0.53
HPGD P15428 2/20 0.53
HTT P42858 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
SYK P43405 2/20 0.49
BRD4 O60885 3/20 0.48
MAPK8 P45983 2/20 0.48
MAPK9 P45984 1/20 0.48
MAPK10 P53779 1/20 0.48
AURKA O14965 1/20 0.47
TTK P33981 1/20 0.47
AURKB Q96GD4 1/20 0.47
INCENP Q9NQS7 1/20 0.47
MAP2K4 P45985 1/20 0.47
CCNB2 O95067 2/20 0.47
CDK1 P06493 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033479 0.87 PTGS2 (0.55) MAPK1MAPK8MAPK9MAPK10AURKA
SCHEMBL1031162 0.86 IKBKB (0.54) ALDH1A1KDM4EHTTTSHRMAPK1
SCHEMBL1034510 0.83 IKBKB (0.57) ALDH1A1KDM4EHPGDHTTNPSR1
SCHEMBL1028968 0.78 MAP4K4 (0.55) KDM4EMAPK1MAPK8MAPK9MAPK10
SCHEMBL1030530 0.78 ADORA1 (0.59) MAPK1MAPK8MAPK9MAPK10CCNB2
SCHEMBL3619159 0.78 ADORA1 (0.59) MAPK1MAPK8MAPK9MAPK10CCNB2
SCHEMBL1033626 0.78 CDK1 (0.53) KDM4EMAPK1MAPK8MAPK9MAPK10
SCHEMBL1033986 0.77 PTK2 (0.49) MAPK1AURKATTKAURKBINCENP
SCHEMBL1034808 0.77 AURKA (0.55) KDM4EHPGDMAPK8MAPK9MAPK10
SCHEMBL1030447 0.76 MAPK14 (0.52) MAPK8MAPK10AURKATTKAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed